2011 Awarded Grant

Jil Tardiff, MD, PhD

Development of a Model System for Tropomyosin-linked Early Onset Dilated Cardiomyopathy
Albert Einstein College of Medicine, Bronx, NY
2011 Amount Awarded – $50,000  

Dilated cardiomyopathy (DCM) is a very common form of cardiomyopathy and carries a particularly poor patient outcome. One of the most important observations in the field in the past decade has been that, like adults, dilated cardiomyopathy in children is often genetic in origin. Moreover, the genetic causes include mutations in known components of the cardiac sarcomere. These striking findings have led to a significant change in our view of the pathogenic mechanisms that cause DCM in children. A novel mutation in alpha-tropomyosin (D230N) a thin filament component of the sarcomere, was recently shown to cause a complex cardiomyopathy that presented in both early childhood with heart failure and sudden death and as a milder form in adults. This "bimodal" distribution of disease onset suggests that the primary DCM mechanism in childhood may change over time and suggests that the normal changes associated with cardiac growth in children are potentially involved. A better understanding of how these native changes in sarcomeric protein expression alter the disease state would provide a novel approach to developing therapies and interventions to alter the progression of this severe form of DCM. The proposed study will look at whether age-dependent changes in the cardiac forms of Troponin T, an important tropomyosin binding partner, drives the age-dependent cardiac remodeling that defines the disease. To fully investigate this hypothesis, a high-throughput in vitro screen and a novel transgenic mouse model carrying the D230N mutation will be utilized.

Stay Informed
Keep current on PCM research and CCF happenings in our Heart to Heart newsletter.
Unite and Fight
Connect with hundreds of other families struggling with this disease through our online member community.
Shop for a Cure
Shop for CCF merchandise to support our research and education efforts.
The Children's Cardiomyopathy Foundation is a 501 (c)(3) non-profit recognized by the U.S. Internal Revenue Service.
© 2020 Children's Cardiomyopathy Foundation. All rights reserved.